
CTCELLS
Operator of a cancer diagnostics and drug development platform intended to improve patient outcomes by matching cancer characteristics with the most suitable therapies. The company specializes in drug...
Valuation
$0
Share Price
N/A
Total Raised
$16.2M
Last Round
N/A